Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Apr 13;181(2):309–322. doi: 10.1007/s10549-020-05630-5

Figure 1.

Figure 1

Lymphovascular invasion (LVI) in primary tumors of TCGA-BRCA cohort. a Kaplan-Meier survival plots along with log-rank test p and hazard ratio (HR) values are shown for association of LVI with progression-free and overall survival. b LVI incidence rates (fractions) as per tumor status for estrogen (ER), HER2, and progesterone (PR) receptors are depicted with barplots. P values were determined with Fisher’s exact test. c Kaplan-Meier survival plots along with log-rank test p values are shown for overall survival among LVI-positive and -negative cases of the cohort sub-grouped by ER, HER2, and PR status.